Andreas Tiede

39PUBLICATIONS

66CO-AUTHORS

Epidemiological methodsBiofabricationApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursHaematology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (39)

Sort by Publication Date:

|Jun 15, 2026

Management of Breakthrough Bleeding During Emicizumab Prophylaxis in Acquired Haemophilia A: Data From the GTH-AHA-EMI Study.

|Feb 03, 2026

Pharmacodynamic Interaction Between Emicizumab and Coagulation Factor VIII.

Matthias Chill, Emma L Konarski, Annika Klingberg

|Aug 12, 2025

Sustained survival benefit of emicizumab and postponed immunosuppression in acquired hemophilia A.

Inga M Schimansky, Christiane Dobbelstein, Robert Klamroth

|Mar 08, 2025

Anti-CD19 CAR-T cell therapy for acquired hemophilia A.

Christian R Schultze-Florey, Felicitas R Thol, Krasimira Aleksandrova

|Apr 02, 2024

Andreas Tiede, Sophie Susen, Ton Lisman

|Sep 27, 2023

von Willebrand factor modulates immune complexes and the recall response against factor VIII in a murine hemophilia A model.

Olga Oleshko, Nadine Vollack-Hesse, Andreas Tiede

Pageof 7

Frequent Collaborators

Flora Peyvandi

Robert Klamroth

Giancarlo Castaman

Christian Pfrepper

Pratima Chowdary

Wolfgang Miesbach

Ton Lisman

Johannes Oldenburg

Alberto Tosetto

Victor Jiménez-Yuste

Frequent Collaborators

Flora Peyvandi

Robert Klamroth

Giancarlo Castaman

Christian Pfrepper